10-Q: PreAxia Q2 2026 Financial Results and Strategic Update
Quarterly Report
PreAxia reports no revenue and a net loss of $857,028 for the six months ended November 30, 2025, as it pivots to AI-powered financial management software.
Summary
- Reported zero revenue for the three and six months ended November 30, 2025.
- Net loss for the six-month period was $857,028, compared to $18,293 in the prior year period.
- Operating expenses increased significantly to $688,189 for the six months, driven by management costs and R&D.
- Cash balance as of November 30, 2025, was $13,846.
- Working capital deficit improved to $754,919 from $2,341,169 as of May 31, 2025, largely due to debt conversions.
- Company is in the development stage for health care payment and personal financial management products.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a high-risk situation due to the lack of revenue, substantial going concern doubt, and the need for significant external capital to fund operations.
Positives
- Significant reduction in working capital deficit from $2,341,169 to $754,919.
- Successful conversion of substantial related party debt into equity, improving the balance sheet.
- Capitalized $129,790 in software development costs, indicating progress on product development.
- Adopted a 2025 Stock Plan to incentivize personnel and consultants.
Negatives
- Zero revenue generation continues to highlight the early-stage nature of the business.
- Substantial net loss of $857,028 for the six-month period.
- Management acknowledges that internal controls over financial reporting were not effective as of November 30, 2025.
- Heavy reliance on related party loans and equity issuance for survival.
Risks
- Substantial doubt exists regarding the ability to continue as a going concern.
- Current cash of $13,846 is insufficient to meet working capital requirements for the next twelve months.
- Requirement to raise an estimated $1,000,000 in additional capital to fund operations and business plan execution.
- Potential for significant dilution to existing shareholders if equity financing is pursued.
- Dependence on the successful development and market adoption of unproven AI-powered financial products.
Future Outlook
The company plans to raise $1,000,000 over the next twelve months to pay creditors and execute its business plan, which includes developing AI-powered personal financial management applications and penetrating markets in Canada and the US.
Management Comments
- Management believes that Canadian businesses are embracing new healthcare financing vehicles.
- Zane's product philosophy centers on the belief that everyone deserves access to genius-level financial guidance.
- The company is creating a personal AI-banker in your pocket.
Industry Context
StockSavvy.ai notes that the company is attempting to pivot from legacy health payment systems to a high-growth AI-driven fintech model, a sector currently characterized by high competition and significant capital requirements for user acquisition.
Comparison to Industry Standards
- The company's lack of revenue and reliance on debt/equity financing is typical for pre-revenue, development-stage fintech startups.
- The pivot to AI-powered 'super-apps' aligns with broader industry trends seen in companies like Chime or Revolut, though PreAxia lacks the scale and capital of these established players.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | N/A | Pavel Bondarev | 2025-06-30 | Appointment as director and CEO of Zane Inc. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Adoption of 2025 Stock Plan | Adopted a plan to issue stock options and warrants to employees and consultants. | 2025-07-01 | Increases potential for share dilution but aids in talent acquisition. |
Legal Proceedings
- Management states there are no material pending legal proceedings.
Related Party Transactions
- Significant debt conversions and accruals related to CEO Tom Zapatinas and Director Pavel Bondarev.
- Employment agreements for Tom Zapatinas and Pavel Bondarev at $10,000 per month each.
Stakeholder Impact
- Shareholders face significant dilution risk from potential future capital raises.
- Creditors are impacted by the company's ongoing liquidity constraints and reliance on debt-to-equity conversions.
Next Steps
- Raise $1,000,000 in additional capital.
- Fill senior management, sales, and engineering positions.
- Develop and launch personal financial management applications.
- Build strategic alliances with employers and insurance companies.
Key Dates
| Date | Description |
|---|---|
| 2000-04-03 | Company incorporation in Nevada. |
| 2025-05-31 | Fiscal year end. |
| 2025-06-30 | Effective date for various management and consulting contracts and debt conversions. |
| 2025-11-30 | Quarterly period end. |
| 2026-04-21 | Filing date of the 10-Q. |
Recommendation
sellThe company is in a precarious financial position with no revenue, substantial losses, and a stated need for significant capital, which will likely lead to further dilution of existing shareholders.
Keywords
PreAxia, Health Care Payment, Fintech, AI-powered banking, Personal financial management, Development stage, 10-Q
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.